206 related articles for article (PubMed ID: 21355725)
1. Associations between improved glucose control and patient-reported outcomes after initiation of insulin pump therapy in patients with type 2 diabetes mellitus.
Peyrot M; Rubin RR; Chen X; Frias JP
Diabetes Technol Ther; 2011 Apr; 13(4):471-6. PubMed ID: 21355725
[TBL] [Abstract][Full Text] [Related]
2. Patient-reported outcomes from a 16-week open-label, multicenter study of insulin pump therapy in patients with type 2 diabetes mellitus.
Rubin RR; Peyrot M; Chen X; Frias JP
Diabetes Technol Ther; 2010 Nov; 12(11):901-6. PubMed ID: 20879963
[TBL] [Abstract][Full Text] [Related]
3. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
Rubin RR; Peyrot M
J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
[TBL] [Abstract][Full Text] [Related]
4. Integrated sensor-augmented pump therapy systems [the MiniMed® Paradigm™ Veo system and the Vibe™ and G4® PLATINUM CGM (continuous glucose monitoring) system] for managing blood glucose levels in type 1 diabetes: a systematic review and economic evaluation.
Riemsma R; Corro Ramos I; Birnie R; Büyükkaramikli N; Armstrong N; Ryder S; Duffy S; Worthy G; Al M; Severens J; Kleijnen J
Health Technol Assess; 2016 Feb; 20(17):v-xxxi, 1-251. PubMed ID: 26933827
[TBL] [Abstract][Full Text] [Related]
5. Satisfaction with continuous glucose monitoring is associated with quality of life in young people with type 1 diabetes regardless of metabolic control and treatment type.
Franceschi R; Pertile R; Marigliano M; Mozzillo E; Maffeis C; Morotti E; Di Candia F; Fedi L; Iafusco D; Zanfardino A; Cauvin V; Maltoni G; Zucchini S; Cherubini V; Tiberi V; Minuto N; Bassi M; Rabbone I; Savastio S; Tinti D; Tornese G; Schiaffini R; Passanisi S; Lombardo F; Bonfanti R; Scaramuzza A; Troncone A
Diabet Med; 2024 Jun; 41(6):e15307. PubMed ID: 38383984
[TBL] [Abstract][Full Text] [Related]
6. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
7. Patient-reported outcomes for an integrated real-time continuous glucose monitoring/insulin pump system.
Peyrot M; Rubin RR
Diabetes Technol Ther; 2009 Jan; 11(1):57-62. PubMed ID: 19132857
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Continuous Glucose Monitoring on Markers of Quality of Life in Adults With Type 1 Diabetes: Further Findings From the DIAMOND Randomized Clinical Trial.
Polonsky WH; Hessler D; Ruedy KJ; Beck RW;
Diabetes Care; 2017 Jun; 40(6):736-741. PubMed ID: 28389582
[TBL] [Abstract][Full Text] [Related]
9. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
Levitt DL; Spanakis EK; Ryan KA; Silver KD
Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
[TBL] [Abstract][Full Text] [Related]
10. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
[TBL] [Abstract][Full Text] [Related]
11. The JDRF CCTN CGM TIME Trial: Timing of Initiation of continuous glucose Monitoring in Established pediatric type 1 diabetes: study protocol, recruitment and baseline characteristics.
Lawson ML; Bradley B; McAssey K; Clarson C; Kirsch SE; Mahmud FH; Curtis JR; Richardson C; Courtney J; Cooper T; Downie CJ; Rajamannar G; Barrowman N; ;
BMC Pediatr; 2014 Jul; 14():183. PubMed ID: 25034216
[TBL] [Abstract][Full Text] [Related]
12. Effect of short-term iPRO continuous glucose monitoring on hemoglobin A1c levels in clinical practice.
Pepper GM; Steinsapir J; Reynolds K
Diabetes Technol Ther; 2012 Aug; 14(8):654-7. PubMed ID: 22690923
[TBL] [Abstract][Full Text] [Related]
13. Comparing Insulin Pump Devices in Real Life: The AWeSoMe Study Group Prospective Experience.
Rachmiel M; Levy-Shraga Y; Gruber N; Pinhas-Hamiel O; Barash G; Pivko-Levy D; Landau Z
Diabetes Technol Ther; 2019 Mar; 21(3):138-145. PubMed ID: 30702335
[TBL] [Abstract][Full Text] [Related]
14. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study.
Buse JB; Kudva YC; Battelino T; Davis SN; Shin J; Welsh JB
Diabetes Technol Ther; 2012 Jul; 14(7):644-7. PubMed ID: 22524549
[TBL] [Abstract][Full Text] [Related]
15. Impact on Diabetes Self-Management and Glycemic Control of a New Color-Based SMBG Meter.
Schnell O; Klausmann G; Gutschek B; Garcia-Verdugo RM; Hummel M
J Diabetes Sci Technol; 2017 Nov; 11(6):1218-1225. PubMed ID: 28443343
[TBL] [Abstract][Full Text] [Related]
16. Emerging diabetes therapies and technologies.
Moser EG; Morris AA; Garg SK
Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
[TBL] [Abstract][Full Text] [Related]
17. Implantable insulin pump vs multiple-dose insulin for non-insulin-dependent diabetes mellitus: a randomized clinical trial. Department of Veterans Affairs Implantable Insulin Pump Study Group.
Saudek CD; Duckworth WC; Giobbie-Hurder A; Henderson WG; Henry RR; Kelley DE; Edelman SV; Zieve FJ; Adler RA; Anderson JW; Anderson RJ; Hamilton BP; Donner TW; Kirkman MS; Morgan NA
JAMA; 1996 Oct 23-30; 276(16):1322-7. PubMed ID: 8861991
[TBL] [Abstract][Full Text] [Related]
18. Effects of real-time continuous glucose monitoring in type 1 diabetes: a meta-analysis of randomized controlled trials.
Dicembrini I; Cosentino C; Monami M; Mannucci E; Pala L
Acta Diabetol; 2021 Apr; 58(4):401-410. PubMed ID: 32789691
[TBL] [Abstract][Full Text] [Related]
19. An exploratory trial of basal and prandial insulin initiation and titration for type 2 diabetes in primary care with adjunct retrospective continuous glucose monitoring: INITIATION study.
Blackberry ID; Furler JS; Ginnivan LE; Manski-Nankervis JA; Jenkins A; Cohen N; Best JD; Young D; Liew D; Ward G; O'Neal DN
Diabetes Res Clin Pract; 2014 Nov; 106(2):247-55. PubMed ID: 25271117
[TBL] [Abstract][Full Text] [Related]
20. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
